Lates News

Merck & Co.: Under the agreement, SciBruch receives an exclusive global license to develop, manufacture, and commercialize SPR2015. SciBrunch will receive a $400 million upfront payment, with total potential consideration for the transaction amounting to $2.13 billion, including the upfront payment.